PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2807 (110th)

Patients First Act of 2007

referredUnited States· United States Congress· EN

Introduced

21 June 2007

Last action

21 June 2007 · Introduced

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Forbes, J. Randy [R-VA-4], Daniel Lipinski, Rep. Pitts, Joseph R. [R-PA-16], Rep. Gingrey, Phil [R-GA-11], Frank Lucas, Rep. Akin, W. Todd [R-MO-2], Tim Walberg, Rescom. Fortuno, Luis G. [R-PR-At Large], Rep. Doolittle, John T. [R-CA-4], Doug Lamborn, Rep. Miller, Jeff [R-FL-1], Christopher Smith, Trent Franks, Sen. Blunt, Roy [R-MO], Rob Bishop, Rep. Sullivan, John [R-OK-1], Rep. Alexander, Rodney [R-LA-5], John Boozman, Rep. McCotter, Thaddeus G. [R-MI-11], Rep. Feeney, Tom [R-FL-24], Jim Jordan, Rep. Sali, Bill [R-ID-1], Rep. Boehner, John A. [R-OH-8], Rep. Terry, Lee [R-NE-2], Rep. Musgrave, Marilyn N. [R-CO-4], Robert Wittman, Rep. Brown, Henry E., Jr. [R-SC-1]

Subjects

Healthcare

Source updated

14 August 2025

Healthcare

Summary

Patients First Act of 2007 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not such pluripotent stem cells have an embryonic source), provided that such techniques will not involve: (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a living human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this Act. Requires the Secretary to issue guidelines implementing this Act to ensure that any research (including any clinical trial) supported under this Act: (1) is clearly consistent with the standards established in this Act, if conducted using human cells; (2) is prioritized in terms of potential for near-term clinical benefit in human patients; and (3) may take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research. Requires the Secretary to: (1) report on peer reviewed stem cell research proposals that were not funded; and (2) study and submit recommendations to Congress on any structural changes to the C.W. Bill Young Cell Transplantation Program that would help to expand access to new and future stem cell therapeutic products.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 21 June 2007

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  2. 21 June 2007

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  3. 21 June 2007

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 21 June 2007

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.